HeartRhythm

MARCH 26, 2024

Wilkoff, MD, one of the most impactful and pioneering members of the Heart Rhythm Society (HRS). Dr Wilkoff was an innovator in the field of cardiac implantable electronic devices (CIEDs).

Heart Rhythm 45

Heart Rhythm Electrophysiology Innovation Technology 45

DAIC

JANUARY 19, 2024

milla1cf Fri, 01/19/2024 - 10:38 January 19, 2024 — Heart rhythm expert Sumeet Chugh, MD , associate director of the Smidt Heart Institute at Cedars-Sinai , is the recipient of this year’s American College of Cardiology ( ACC ) Distinguished Scientist Award-Clinical Domain. Photo by Cedars-Sinai.

Cardiac Arrest 105

Cardiac Arrest Heart Rhythm Electrophysiology Heart Attack 105

DAIC

JULY 16, 2024

At the forefront of PowerPlugs is AFib Detection , a PowerPlug that discreetly monitors your heart rhythm every night to detect signs of Atrial Fibrillation (AFib). AFib is the most common type of irregular heart rhythm or arrhythmia. UltraSignal will help fuel more customization and innovation in health.

AFIB 103

AFIB Technology Heart Rhythm Arrhythmia 103

DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

DAIC

JANUARY 24, 2024

The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias—abnormal heartbeats that start in the heart’s two lower chambers—and an elevated risk of sudden cardiac death in patients with mitral valve disease. Patients come to us from all over the U.S.

Bicuspid/Mitral 105

Bicuspid/Mitral Research Heart Valves Cardiac Arrest 105

DAIC

FEBRUARY 2, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , revealed findings from a company-funded study of real-world data. AFib is the most common type of cardiac arrhythmia and affects more than 6 million people in the United States and nearly 38 million people worldwide.2,3

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

DAIC

MAY 21, 2024

milla1cf Tue, 05/21/2024 - 08:00 May 21, 2024 — Stereotaxis , a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024 , scheduled to take place during Heart Rhythm Society Scientific Sessions in Boston, Massachusetts.

Heart Rhythm 52

Heart Rhythm Innovation Electrophysiology Technology 52

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). [ii]

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

Vector Remote

APRIL 14, 2023

History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technological innovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.

Pacemaker 52

Pacemaker Technology COVID-19 Blood Pressure 52

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

Cardiomatics

AUGUST 4, 2022

Over a short time, it is able to detect 20 different arrhythmias. It can help shorten queues to cardiologists, extend prevention and treatment to a wider group of patients, offer precise and early detection of heart rhythm abnormalities, reduce bureaucracy , and increase time for doctor-patient contact.

Cardiovascular Disease 52

Cardiovascular Disease Technology COVID-19 Cerebrovascular Disease 52

DAIC

MARCH 28, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTec h i , announced the submission of the VARIPULSE Platform for Premarket Approval Application (PMA) to the U.S. milla1cf Thu, 03/28/2024 - 07:28 March 28, 2024 — Biosense Webster, Inc., Food & Drug Administration ( FDA ).

Atrial Fibrillation 110

Atrial Fibrillation AFIB Ablation Pulmonary 110

DAIC

DECEMBER 22, 2023

David Newton , Clinical Cardiac Electrophysiologist at Memorial Health University Physicians Heart Care and Dr. Andrea Natale , Executive Medical Director at T exas Cardiac Arrhythmia Institute, St. David’s Medical Center. Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.

Atrial Fibrillation 59

Atrial Fibrillation AFIB Ablation Heart Rhythm 59

DAIC

APRIL 6, 2024

EDT, the ACC will present Sumeet Chugh, MD , associate director of the Smidt Heart Institute, with this year’s Distinguished Scientist Award-Clinical Domain. Gupta is one of 28 structural heart cardiologists and surgeons selected for CTR’s new Project REACH. EDT, and she will co-chair electrophysiology research presentations.

Research 105

Research Cardiac Arrest Electrophysiology Chest Pain 105